Siest G, Batt A M, Galteau M M
Ann Biol Clin (Paris). 1977;35(6):425-32.
Laboratory tests are increasingly important in the surveillance of drug treatments. People in charge of clinical laboratory science must now become aware of a new development, the use of as indicators of the activity of drug-metabolizing enzymes, especially of the induction of such enzymes. Ideally, the activity of such enzymes should be measured in the tissues. In man, however, easier indirect methods of application are now most often used : measurement of antipyrine half-life, urinary and plasma drug metabolites, protein and specific enzyme levels in palsma, changes in endogenous substrates and endogenous metabolites, and enzymes in circulating blood cells. Of all these, two examinations are now widely performed, those for urinary glucaric acid and gamma-glutamyltrasferase. The value and limitations of these two tests are discussed.
实验室检测在药物治疗监测中日益重要。临床检验科学的负责人现在必须了解一项新进展,即使用某些物质作为药物代谢酶活性的指标,尤其是此类酶的诱导指标。理想情况下,此类酶的活性应在组织中进行测量。然而,在人类中,目前最常使用更简便的间接方法:测量安替比林半衰期、尿液和血浆中的药物代谢物、血浆中的蛋白质和特定酶水平、内源性底物和内源性代谢物的变化,以及循环血细胞中的酶。在所有这些方法中,目前有两项检测被广泛应用,即尿液中葡萄糖醛酸和γ-谷氨酰转移酶的检测。本文讨论了这两项检测的价值和局限性。